Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: A multi-electrode array study

APP.V717I and Tau.P301L transgenic mice develop Alzheimer's disease pathology comprising important aspects of human disease including increased levels of amyloid peptides, cognitive and motor impairment, amyloid plaques and neurofibrillary tangles. The combined model, APP.V717I×Tau.P301L bigenic mice (biAT mice) exhibit aggravated amyloid and tau pathology with severe cognitive and behavioral defects. In the present study, we investigated early changes in synaptic function in the CA1 and CA3 regions of acute hippocampal slices of young APP.V717I, Tau.P301L and biAT transgenic animals. We have used planar multi-electrode arrays (MEA) and improved methods for simultaneous multi-site recordings from two hippocampal sub-regions. In the CA1 region, long-term potentiation (LTP) was severely impaired in all transgenic animals when compared with age-matched wild-type controls, while basal synaptic transmission and paired-pulse facilitation were minimally affected. In the CA3 region, LTP was normal in Tau.P301L and APP.V717I but clearly impaired in biAT mice. Surprisingly, frequency facilitation in CA3 was significantly enhanced in Tau.P301L mice, while not affected in APP.V717I mice and depressed in biAT mice. The findings demonstrate important synaptic changes that differ considerably in the hippocampal sub-regions already at young age, well before the typical amyloid or tau pathology is evident.

[1]  D. Manahan‐Vaughan,et al.  Frequency Facilitation at Mossy Fiber–CA3 Synapses of Freely Behaving Rats Is Regulated by Adenosine A1 Receptors , 2008, The Journal of Neuroscience.

[2]  F. van Leuven,et al.  Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.

[3]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[4]  Shaomin Li,et al.  Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.

[5]  Benjamin J. Whalley,et al.  Development of multi-electrode array screening for anticonvulsants in acute rat brain slices , 2010, Journal of Neuroscience Methods.

[6]  S. Heinemann,et al.  Deficits in Synaptic Transmission and Learning in Amyloid Precursor Protein (APP) Transgenic Mice Require C-Terminal Cleavage of APP , 2006, The Journal of Neuroscience.

[7]  G. Collingridge,et al.  Presynaptic mechanisms involved in the expression of STP and LTP at CA1 synapses in the hippocampus , 2007, Neuropharmacology.

[8]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[9]  E. Godaux,et al.  Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice , 2009, Neurobiology of Aging.

[10]  Dietmar Schmitz,et al.  Synaptic plasticity at hippocampal mossy fibre synapses , 2005, Nature Reviews Neuroscience.

[11]  Ghiam Yamin.  NMDA receptor–dependent signaling pathways that underlie amyloid β‐protein disruption of LTP in the hippocampus , 2009, Journal of neuroscience research.

[12]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[13]  Herman Buschke,et al.  Please Scroll down for Article International Review of Psychiatry Mild Cognitive Impairment: Believe It or Not? Mild Cognitive Impairment: Believe It or Not? , 2022 .

[14]  H. Devijver,et al.  Neurobiology Amyloid Activates GSK-3 to Aggravate Neuronal Tauopathy in Bigenic Mice , 2008 .

[15]  T. Ben-Hur,et al.  A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics , 2008, Experimental Neurology.

[16]  S. Grant,et al.  Recording long-term potentiation of synaptic transmission by three-dimensional multi-electrode arrays , 2006, BMC Neuroscience.

[17]  F. van Leuven,et al.  Upper Airway Dysfunction of Tau-P301L Mice Correlates with Tauopathy in Midbrain and Ponto-Medullary Brainstem Nuclei , 2010, The Journal of Neuroscience.

[18]  S. Henriksen,et al.  In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice , 2000, Brain Research.

[19]  H. Zoghbi,et al.  Neurobiology of disease , 2000, Current Opinion in Neurobiology.

[20]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Bertrand,et al.  The adult rat hippocampal slice revisited with multi-electrode arrays , 2006, Brain Research.

[22]  J. Sarvey,et al.  Long-term potentiation: studies in the hippocampal slice , 1989, Journal of Neuroscience Methods.

[23]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[24]  S. Kügler,et al.  Alzheimer's disease: old problem, new views from transgenic and viral models. , 2010, Biochimica et biophysica acta.

[25]  J. Götz,et al.  Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease* , 2009, The Journal of Biological Chemistry.

[26]  Shaoqun Zeng,et al.  Long-term recording on multi-electrode array reveals degraded inhibitory connection in neuronal network development. , 2007, Biosensors & bioelectronics.

[27]  I. Tesseur,et al.  Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London mice , 2000, Experimental Gerontology.

[28]  Daniel Johnston,et al.  Multiple forms of LTP in hippocampal CA3 neurons use a common postsynaptic mechanism , 1999, Nature Neuroscience.

[29]  L. Buée,et al.  P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.

[30]  Hilmar Bading,et al.  Long term recordings with microelectrode arrays: Studies of transcription-dependent neuronal plasticity and axonal regeneration , 2006, Journal of Physiology-Paris.

[31]  Gary Lynch,et al.  Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice , 1999, Brain Research.

[32]  J. Behr,et al.  Activation of dopamine D1/D5 receptors facilitates the induction of presynaptic long‐term potentiation at hippocampal output synapses , 2010, The European journal of neuroscience.

[33]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[34]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[35]  H. Oka,et al.  A new planar multielectrode array for extracellular recording: application to hippocampal acute slice , 1999, Journal of Neuroscience Methods.

[36]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[37]  T. Teyler.  Long-term potentiation and memory. , 1987, International journal of neurology.

[38]  G. Collingridge,et al.  Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein , 2001, The Journal of Neuroscience.

[39]  E. Mandelkow,et al.  MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons , 2004, The Journal of cell biology.

[40]  Inna Kuperstein,et al.  Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio , 2010, The EMBO journal.

[41]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[42]  J. Luebke,et al.  Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs , 2010, Experimental Neurology.

[43]  I. Forsythe,et al.  Presynaptic Mitochondrial Calcium Sequestration Influences Transmission at Mammalian Central Synapses , 2002, The Journal of Neuroscience.

[44]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[45]  Jürgen Götz,et al.  Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.

[46]  S. Kügler,et al.  AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice , 2009, PloS one.

[47]  R. Nitsch,et al.  Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice , 2006, Genes, brain, and behavior.

[48]  R. Wade-Martins,et al.  Knock-out and transgenic mouse models of tauopathies , 2009, Neurobiology of Aging.

[49]  Hilmar Bading,et al.  Microelectrode array recordings of cultured hippocampal networks reveal a simple model for transcription and protein synthesis‐dependent plasticity , 2005, The Journal of physiology.

[50]  Ottavio Arancio,et al.  A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment , 2008, Neurobiology of Disease.

[51]  Paul Antoine Salin,et al.  Distinct short-term plasticity at two excitatory synapses in the hippocampus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Südhof,et al.  Presenilins are Essential for Regulating Neurotransmitter Release , 2009, Nature.

[53]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[54]  Ger J. A. Ramakers,et al.  Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and Tauopathy , 2006, The Journal of Neuroscience.